ORIC Pharmaceuticals, Inc. (ORIC) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$10.98
Day's range
$12.95

ORIC Pharmaceuticals Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
NEXTECH INVEST, LTD. 05/15/2026 7.16 M $90.75 M   0.00% 6.79%
ECOR1 CAPITAL, LLC 05/15/2026 6.73 M $85.25 M   0.00% 6.38%
BLACKROCK, INC. 05/13/2026 5.98 M $75.82 M   1.86% 5.67%
VIKING GLOBAL INVESTORS LP 05/15/2026 5.82 M $73.80 M   -11.38% 5.52%
PRICE T ROWE ASSOCIATES INC /MD/ 05/15/2026 5.39 M $68.26 M   63.51% 5.11%
PFIZER INC 05/12/2026 4.78 M $57.65 M   -11.08% 4.53%
SR ONE CAPITAL MANAGEMENT, LP 05/14/2026 4.51 M $58.48 M   0.00% 4.28%
ALKEON CAPITAL MANAGEMENT LLC 05/15/2026 4.50 M $57.07 M   0.00% 4.27%
VR ADVISER, LLC 05/15/2026 4.32 M $54.73 M   -23.90% 4.10%
NEA MANAGEMENT COMPANY, LLC 05/15/2026 4.12 M $52.18 M   0.00% 3.90%
STATE STREET CORP 05/15/2026 3.70 M $46.91 M   -13.06% 3.51%
VANGUARD CAPITAL MANAGEMENT LLC 05/15/2026 3.69 M $46.71 M   100.00% 3.50%
COLUMN GROUP LLC 05/18/2026 3.54 M $44.86 M   0.00% 3.36%
SIREN, L.L.C. 05/14/2026 3.00 M $37.99 M   197.57% 2.84%
ORBIMED ADVISORS LLC 05/15/2026 2.69 M $34.13 M   -26.03% 2.55%
05/08/2026 2.46 M $31.16 M   100.00% 2.33%
FMR LLC 05/15/2026 2.43 M $30.84 M   -1.81% 2.31%
CITADEL ADVISORS LLC 05/15/2026 2.42 M $30.70 M   -0.49% 2.30%
FIRST TURN MANAGEMENT, LLC 05/15/2026 2.02 M $25.56 M   0.35% 1.91%
VIVO CAPITAL, LLC 05/20/2026 1.85 M $23.42 M   -12.73% 1.75%
GEODE CAPITAL MANAGEMENT, LLC 05/15/2026 1.84 M $23.30 M   5.03% 1.74%
BIOIMPACT CAPITAL LLC 05/15/2026 1.80 M $22.86 M   0.29% 1.71%
PARADIGM BIOCAPITAL ADVISORS LP 05/15/2026 1.70 M $21.55 M   -29.15% 1.61%
MORGAN STANLEY 05/15/2026 1.68 M $21.32 M   40.91% 1.60%
GOLDMAN SACHS GROUP INC 05/15/2026 1.48 M $18.70 M   -23.90% 1.40%
DIMENSIONAL FUND ADVISORS LP 05/07/2026 1.47 M $18.64 M   19.89% 1.39%
FRANKLIN RESOURCES INC 05/13/2026 1.45 M $18.41 M   19.82% 1.38%
INTEGRAL HEALTH ASSET MANAGEMENT, LLC 05/15/2026 1.40 M $17.74 M   16.67% 1.33%
WOODLINE PARTNERS LP 05/15/2026 1.25 M $15.81 M   406.02% 1.18%
ROYCE & ASSOCIATES LP 05/12/2026 1.21 M $15.30 M   -19.91% 1.14%
BRAIDWELL LP 05/15/2026 1.13 M $14.29 M   100.00% 1.07%
SILVERARC CAPITAL MANAGEMENT, LLC 05/14/2026 1.10 M $13.94 M   -1.49% 1.04%
BANK OF AMERICA CORP /DE/ 05/18/2026 1.04 M $13.22 M   105.54% 0.99%
EUCLIDEAN CAPITAL LLC 05/15/2026 989.41 K $12.54 M   0.00% 0.94%
ARROWMARK COLORADO HOLDINGS LLC 05/15/2026 960.52 K $12.17 M   -9.71% 0.91%
EVENTIDE ASSET MANAGEMENT, LLC 05/15/2026 953.45 K $12.08 M   0.11% 0.90%
LOGOS GLOBAL MANAGEMENT LP 05/15/2026 950.00 K $12.04 M   111.11% 0.90%
QUBE RESEARCH & TECHNOLOGIES LTD 05/15/2026 859.49 K $10.89 M   -28.70% 0.81%
06/12/2026 842.93 K $10.68 M   100.00% 0.80%
NORTHERN TRUST CORP 05/14/2026 710.86 K $9.01 M   -19.72% 0.67%
SOFINNOVA INVESTMENTS, INC. 05/15/2026 679.58 K $8.61 M   100.00% 0.64%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 05/15/2026 605.04 K $7.67 M   -2.58% 0.57%
CANDRIAM S.C.A. 04/30/2026 574.09 K $7.27 M   100.00% 0.54%
05/08/2026 570.69 K $7.23 M   100.00% 0.54%
LORD, ABBETT & CO. LLC 05/14/2026 542.60 K $6.88 M   -3.84% 0.51%
POLAR CAPITAL HOLDINGS PLC 05/15/2026 539.38 K $6.83 M   7.37% 0.51%
SPHERA FUNDS MANAGEMENT LTD. 05/15/2026 537.63 K $6.81 M   -46.47% 0.51%
BALYASNY ASSET MANAGEMENT L.P. 05/15/2026 523.79 K $6.64 M   -44.88% 0.50%
05/14/2026 523.62 K $6.63 M   -14.96% 0.50%
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. 05/11/2026 522.06 K $6.61 M   48.78% 0.50%

ORIC Pharmaceuticals Inc institutional Ownership - FAQ's

During the previous two years, 217 institutional investors and hedge funds held shares of ORIC Pharmaceuticals Inc. The most heavily invested institutionals were:

CITIGROUP INC: 248,757

TD ASSET MANAGEMENT INC: 246,002

Bank of New York Mellon Corp: 220,080

Russell Investments Group, Ltd.: 99,742

TEMA ETFS LLC: 57,977

AXQ CAPITAL, LP: 36,519

113.17% of ORIC Pharmaceuticals Inc stock is owned by institutional investors.

Institutional investors have bought a total of 134.18 M shares in the last 24 months. This purchase volume represents approximately $1.56 B in transactions.